Unusually short unsupported Au(III)⋯Au(III) aurophilic contacts in emissive lanthanide tetracyanoaurate(III) complexes.

A series of [Au(CN)4]- salts with lanthanide 2,2'-bipyridine dioxide cations features Au(III) aurophilic interactions between [Au(CN)4]- groups, with Au⋯Au distances of 3.3603(4) Šand 3.4354(4) Šthat are shorter than any previously reported. Computations predict the interactions to be weakly attractive; packing effects appear to also contribute to the close contacts. The materials are emissive: there is no Au(III)-based luminescence, but for Ln = Eu the PLQY of 29% is surprisingly high compared to related analogues.

Untangling ancillary ligand donation versus locus of oxidation effects on metal nitride reactivity.

We detail the relative role of ancillary ligand electron-donating ability in comparison to the locus of oxidation (either metal or ligand) on the electrophilic reactivity of a series of oxidized Mn salen nitride complexes. The electron-donating ability of the ancillary salen ligand was tuned via the para-phenolate substituent (R = CF3, H, tBu, OiPr, NMe2, NEt2) in order to have minimal effect on the geometry at the metal center. Through a suite of experimental (electrochemistry, electron paramagnetic resonance spectroscopy, UV-vis-NIR spectroscopy) and theoretical (density functional theory) techniques, we have demonstrated that metal-based oxidation to [MnVI(SalR)N]+ occurs for R = CF3, H, tBu, OiPr, while ligand radical formation to [MnV(SalR)N]+˙ occurs with the more electron-donating substituents R = NMe2, NEt2. We next investigated the reactivity of the electrophilic nitride with triarylphosphines to form a MnIV phosphoraneiminato adduct and determined that the rate of reaction decreases as the electron-donating ability of the salen para-phenolate substituent is increased. Using a Hammett plot, we find a break in the Hammett relation between R = OiPr and R = NMe2, without a change in mechanism, consistent with the locus of oxidation exhibiting a dominant effect on nitride reactivity, and not the overall donating ability of the ancillary salen ligand. This work differentiates between the subtle and interconnected effects of ancillary ligand electron-donating ability, and locus of oxidation, on electrophilic nitride reactivity.

Targeting misfolding and aggregation of the amyloid-ß peptide and mutant p53 protein using multifunctional molecules.

Biomolecule misfolding and aggregation play a major role in human disease, spanning from neurodegeneration to cancer. Inhibition of these processes is of considerable interest, and due to the multifactorial nature of these diseases, the development of drugs that act on multiple pathways simultaneously is a promising approach. This Feature Article focuses on the development of multifunctional molecules designed to inhibit the misfolding and aggregation of the amyloid-ß (Aß) peptide in Alzheimer's disease (AD), and the mutant p53 protein in cancer. While for the former, the goal is to accelerate the removal of the Aß peptide and associated aggregates, for the latter, the goal is reactivation via stabilization of the active folded form of mutant p53 protein and/or aggregation inhibition. Due to the similar aggregation pathway of the Aß peptide and mutant p53 protein, a common therapeutic approach may be applicable.

Altering relative metal-binding affinities in multifunctional Metallochaperones for mutant p53 reactivation.

The p53 protein plays a major role in cancer prevention, and over 50% of cancer diagnoses can be attributed to p53 malfunction. p53 incorporates a structural Zn site that is required for proper protein folding and function, and in many cases point mutations can result in loss of the Zn2+ ion, destabilization of the tertiary structure, and eventual amyloid aggregation. Herein, we report a series of compounds designed to act as small molecule stabilizers of mutant p53, and feature Zn-binding fragments to chaperone Zn2+ to the metal depleted site and restore wild-type (WT) function. Many Zn metallochaperones (ZMCs) have been shown to generate intracellular reactive oxygen species (ROS), likely by chelating redox-active metals such as Fe2+/3+ and Cu+/2+ and undergoing associated Fenton chemistry. High levels of ROS can result in off-target effects and general toxicity, and thus, careful tuning of ligand Zn2+ affinity, in comparison to the affinity for other endogenous metals, is important for selective mutant p53 targeting. In this work we show that by using carboxylate donors in place of pyridine we can change the relative Zn2+/Cu2+ binding ability in a series of ligands, and we investigate the impact of donor group changes on metallochaperone activity and overall cytotoxicity in two mutant p53 cancer cell lines (NUGC3 and SKGT2).

Multifunctional metallochaperone modifications for targeting subsite cavities in mutant p53-Y220C.

The p53 protein, known as the 'guardian of the genome', plays an important role in cancer prevention. Unfortunately, p53 mutations result in compromised activity with over 50% of cancers resulting from point mutations to p53. There is considerable interest in mutant p53 reactivation, with the development of small-molecule reactivators showing promise. We have focused our efforts on the common p53 mutation Y220C, which causes protein unfolding, aggregation, and can result in the loss of a structural Zn from the DNA-binding domain. In addition, the Y220C mutant creates a surface pocket that can be stabilized using small molecules. We previously reported the bifunctional ligand L5 as a Zn metallochaperone and reactivator of the p53-Y220C mutant. Herein we report two new ligands L5-P and L5-O that are designed to act as Zn metallochaperones and non-covalent binders in the Y220C mutant pocket. For L5-P the distance between the Zn-binding di-(2-picolyl)amine function and the pocket-binding diiodophenol was extended in comparison to L5, while for L5-O we extended the pocket-binding moiety via attachment of an alkyne function. While both new ligands displayed similar Zn-binding affinity to L5, neither acted as efficient Zn-metallochaperones. However, the new ligands exhibited significant cytotoxicity in the NCI-60 cell line screen as well as in the NUGC3 Y220C mutant cell line. We identified that the primary mode of cytotoxicity is likely reactive oxygen species (ROS) generation for L5-P and L5-O, in comparison to mutant p53 reactivation for L5, demonstrating that subtle changes to the ligand scaffold can change the toxicity pathway.

Inhibition of p53 protein aggregation as a cancer treatment strategy.

The p53 protein plays a critical role in the prevention of genome mutations in the body, however, this protein is frequently mutated in cancer and almost all cancers exhibit malfunction along the p53 pathway. In addition to a loss of activity, mutant p53 protein is prone to unfolding and aggregation, eventually forming amyloid aggregates. There continues to be a considerable effort to develop strategies to restore normal p53 expression and activity and this review details recent advances in small-molecule stabilization of mutant p53 protein and the design of p53 aggregation inhibitors.

Chromium Nitride Umpolung Tuned by the Locus of Oxidation.

Oxidation of a series of CrV nitride salen complexes (CrVNSalR) with different para-phenolate substituents (R = CF3, tBu, NMe2) was investigated to determine how the locus of oxidation (either metal or ligand) dictates reactivity at the nitride. Para-phenolate substituents were chosen to provide maximum variation in the electron-donating ability of the tetradentate ligand at a site remote from the metal coordination sphere. We show that one-electron oxidation affords CrVI nitrides ([CrVINSalR]+; R = CF3, tBu) and a localized CrV nitride phenoxyl radical for the more electron-donating NMe2 substituent ([CrVNSalNMe2]•+). The facile nitride homocoupling observed for the MnVI analogues was significantly attenuated for the CrVI complexes due to a smaller increase in nitride character in the M≡N π* orbitals for Cr relative to Mn. Upon oxidation, both the calculated nitride natural population analysis (NPA) charge and energy of molecular orbitals associated with the {Cr≡N} unit change to a lesser extent for the CrV ligand radical derivative ([CrVNSalNMe2]•+) in comparison to the CrVI derivatives ([CrVINSalR]+; R = CF3, tBu). As a result, [CrVNSalNMe2]•+ reacts with B(C6F5)3, thus exhibiting similar nucleophilic reactivity to the neutral CrV nitride derivatives. In contrast, the CrVI derivatives ([CrVINSalR]+; R = CF3, tBu) act as electrophiles, displaying facile reactivity with PPh3 and no reaction with B(C6F5)3. Thus, while oxidation to the ligand radical does not change the reactivity profile, metal-based oxidation to CrVI results in umpolung, a switch from nucleophilic to electrophilic reactivity at the terminal nitride.

A role for bioinorganic chemistry in the reactivation of mutant p53 in cancer.

Metal ion dysregulation has been implicated in a number of diseases from neurodegeneration to cancer. While defective metal ion transport mechanisms are known to cause specific diseases of genetic origin, the role of metal dysregulation in many diseases has yet to be elucidated due to the complicated function (both good and bad!) of metal ions in the body. A breakdown in metal ion speciation can manifest in several ways from increased reactive oxygen species (ROS) generation to an increase in protein misfolding and aggregation. In this review, we will discuss the role of Zn in the proper function of the p53 protein in cancer. The p53 protein plays a critical role in the prevention of genome mutations via initiation of apoptosis, DNA repair, cell cycle arrest, anti-angiogenesis, and senescence pathways to avoid propagation of damaged cells. p53 is the most frequently mutated protein in cancer and almost all cancers exhibit malfunction along the p53 pathway. Thus, there has been considerable effort dedicated to restoring normal p53 expression and activity to mutant p53. This includes understanding the relative populations of the Zn-bound and Zn-free p53 in wild-type and mutant forms, and the development of metallochaperones to re-populate the Zn binding site to restore mutant p53 activity. Parallels will be made to the development of multifunctional metal binding agents for modulating the aggregation of the amyloid-beta peptide in Alzheimer's Disease (AD).

Elaboration on the Electronics of Salen Manganese Nitrides: Investigations into Alkoxy-Substituted Ligand Scaffolds.

The ligand electronics of salen manganese nitride complexes directly influence the locus of oxidation and, thus, the reactivity of the resulting oxidized species. This work investigates the influence of tert-butoxy, isopropoxy, and methoxy substituents on the electronics of salen manganese nitride species and includes the first documentation of the para Hammett value for the tert-butoxy substituent (σpara = -0.13 ± 0.03). Each alkoxy-substituted complex undergoes metal-based oxidation to form manganese(VI), and the kinetics of bimolecular homocoupling to form N2 were assessed by cyclic voltammetry. Bis-oxidation of the manganese complexes was investigated at low temperature using cyclic voltammery and UV-vis-near-IR spectroscopy, and in combination with theoretical calculations, plausible electronic structures of the dications are provided.

Exciton Coupling in Redox-Active Salen based Self-Assembled Metallacycles.

The incorporation of a redox-active nickel salen complex into supramolecular structures was explored via coordination-driven self-assembly with homobimetallic ruthenium complexes (bridged by oxalato or 5,8-dihydroxy-1,4-naphthoquinato ligands). The self-assembly resulted in the formation of a discrete rectangle using the oxalato complex and either a rectangle or a catenane employing the larger naphthoquinonato complex. The formation of the interlocked self-assembly was determined to be solvent and concentration dependent. The electronic structure and stability of the oxidized metallacycles was probed using electrochemical experiments, UV-Vis-NIR absorption, EPR spectroscopy and DFT calculations, confirming ligand radical formation. Exciton coupling of the intense near-infrared (NIR) ligand radical intervalence charge transfer (IVCT) bands provided further confirmation of the geometric and electronic structures in solution.

Modification of amyloid-beta peptide aggregation via photoactivation of strained Ru(ii) polypyridyl complexes.

Alzheimer's disease (AD) is a chronic neurodegenerative disorder characterized by progressive and irreversible damage to the brain. One of the hallmarks of the disease is the presence of both soluble and insoluble aggregates of the amyloid beta (Aß) peptide in the brain, and these aggregates are considered central to disease progression. Thus, the development of small molecules capable of modulating Aß peptide aggregation may provide critical insight into the pathophysiology of AD. In this work we investigate how photoactivation of three distorted Ru(ii) polypyridyl complexes (Ru1-3) alters the aggregation profile of the Aß peptide. Photoactivation of Ru1-3 results in the loss of a 6,6'-dimethyl-2,2'-bipyridyl (6,6'-dmb) ligand, affording cis-exchangeable coordination sites for binding to the Aß peptide. Both Ru1 and Ru2 contain an extended planar imidazo[4,5-f][1,10]phenanthroline ligand, as compared to a 2,2'-bipyridine ligand for Ru3, and we show that the presence of the phenanthroline ligand promotes covalent binding to Aß peptide His residues, and in addition, leads to a pronounced effect on peptide aggregation immediately after photoactivation. Interestingly, all three complexes resulted in a similar aggregate size distribution at 24 h, forming insoluble amorphous aggregates as compared to significant fibril formation for peptide alone. Photoactivation of Ru1-3 in the presence of pre-formed Aß1-42 fibrils results in a change to amorphous aggregate morphology, with Ru1 and Ru2 forming large amorphous aggregates immediately after activation. Our results show that photoactivation of Ru1-3 in the presence of either monomeric or fibrillar Aß1-42 results in the formation of large amorphous aggregates as a common endpoint, with Ru complexes incorporating the extended phenanthroline ligand accelerating this process and thereby limiting the formation of oligomeric species in the initial stages of the aggregation process that are reported to show considerable toxicity.

A balancing act: using small molecules for therapeutic intervention of the p53 pathway in cancer.

Referred to as the "guardian of the genome", p53 is the most frequently mutated protein in cancer and almost all cancers exhibit malfunction along the p53 pathway. As an overexpressed and tumour-specific target, the past two decades have seen considerable dedication to the development of small molecules that aim to restore wild-type function in mutant p53. In this review we collect and communicate the chemical principles involved in small molecule drug design for misfolded proteins in anticancer therapy. While this approach has met with significant challenges including off-target mechanisms that induce cytotoxicity independent of p53 status, major technological advancements in gene sequencing capability and a shift towards personalized medicine holds significant promise for p53 reactivating compounds and could have widespread benefits for the field of cancer therapy.

Effect of Distortions on the Geometric and Electronic Structures of One-Electron Oxidized Vanadium(IV), Copper(II), and Cobalt(II)/(III) Salen Complexes.

The ligands N,N'-bis(3-tert-butyl-5-methoxysalicylidene)-1,2-ethanediamine and N,N'-bis(3-tert-butyl-5-methoxysalicylidene)-1,3-propanediamine were chelated to V(IV)═O (1, 2), Cu(II) (3, 4), Co(II) (5), and Co(III) (6). The X-ray crystal structures of 1-6 were solved. The vanadium center in 1-2 resides in square pyramidal geometry, with an axially bound oxo ligand, whereas the metal ion displays a tetrahedrally distorted square planar geometry in 3-5. The extent of distortion is correlated to the length of the diamine spacer: The longer the linker, the larger the tetrahedral distortions. Complex 6 is octahedral with a bidentate acetate molecule that completes the coordination sphere. All the complexes were characterized by UV-vis and EPR spectroscopies, as well as DFT calculations and electrochemistry. Complexes 1-6 exhibit a reversible one-electron oxidation wave in the range -0.11-0.26 V vs Fc+/Fc. The cations 1+ and 2+ were structurally characterized, showing an octahedral V(V) ion with one oxo and one water molecule coordinated in axial positions. Their vis-NIR spectra are dominated by a band at 727 and 815 nm, respectively, which is assigned to a phenolate-to-vanadium(V) charge transfer (CT) transition. The crystal structures of 3+ and 4+ are congruent with Cu(II)-radical species, wherein the metal center remains four-coordinated. Both feature a Class II (Robin-Day classification scale) IVCT transition at around 1200 nm (ε > 1 mM cm-1), indicative of partial localization of the radical. The structure of 5+ displays a square pyramidal cobalt ion, where the fifth (axial) coordination is occupied by a water molecule. It displays a NIR feature at 1244 nm and is described as intermediate between high spin Co(III) and Co(II) radical. In the presence of acetate the dimer [(5)2(µ-OAc)]+ forms, which was structurally characterized and shows a blue shift and lowering in intensity of the NIR absorption band in comparison to 5+. Complex 6+ is a genuine Co(III) radical complex, wherein the phenoxyl moiety is localized on one side of the molecule.

Stabilization of different redox levels of a tridentate benzoxazole amidophenoxide ligand when bound to Co(iii) or V(v).

A tridentate benzoxazole-containing aminophenol ligand NNOH2 was coordinated to Co and V metal centers and the electronic structure of the resultant complexes characterized by both experimental and theoretical methods. The solid state structure of the Co complex exhibits a distorted octahedral geometry with two tridentate ligands bound in meridional fashion, and coordination-sphere bond lengths consistent with a Co(iii) oxidation state. EPR and magnetic data support a S = 1/2 ground state, and a formal electronic description of Co(iii)(NNOAP)(NNOISQ) where NNOAP corresponds to an amidophenoxide and NNOISQ to the iminosemiquinone redox level. However, the metrical parameters are similar for both ligands in the solid state, and DFT calculations support delocalization of the ligand radical over both ligands, affording an intermediate ligand redox level Co(iii)(NNO1.5-)(NNO1.5-). The vanadyl complex exhibits a distorted octahedral geometry in the solid state consistent with a V(v) metal center and amidophenoxide (NNOAP), acetylacetonate and oxo ligands. The ligand metrical parameters are consistent with significant amidophenoxide to V(v) π donation. Overall, our results highlight the roles of electron transfer, delocalization, and π bonding in the metal complexes under study, and thus the complexity in assignment of the electronic structure in these systems.

Coordination-driven assembly of a supramolecular square and oxidation to a tetra-ligand radical species.

The design and synthesis of a supramolecular square was achieved by coordination-driven assembly of redox-active nickel(ii) salen linkers and (ethylenediamine)palladium(ii) nodes. The tetrameric geometry of the supramolecular structure was confirmed via MS, NMR, and electrochemical experiments. While oxidation of the monomeric metalloligand Schiff-base affords a Ni(iii) species, oxidation of the coordination-driven assembly results in ligand radical formation.

A catalytic antioxidant for limiting amyloid-beta peptide aggregation and reactive oxygen species generation.

Alzheimer's disease (AD) is a multifaceted disease that is characterized by increased oxidative stress, metal-ion dysregulation, and the formation of intracellular neurofibrillary tangles and extracellular amyloid-ß (Aß) aggregates. In this work we report the large affinity binding of the iron(iii) 2,17-bis-sulfonato-5,10,15-tris(pentafluorophenyl)corrole complex FeL1 to the Aß peptide (K d ∼ 10-7) and the ability of the bound FeL1 to act as a catalytic antioxidant in both the presence and absence of Cu(ii) ions. Specific findings are that: (a) an Aß histidine residue binds axially to FeL1; (b) that the resulting adduct is an efficient catalase; (c) this interaction restricts the formation of high molecular weight peptide aggregates. UV-Vis and electron paramagnetic resonance (EPR) studies show that although the binding of FeL1 does not influence the Aß-Cu(ii) interaction (K d ∼ 10-10), bound FeL1 still acts as an antioxidant thereby significantly limiting reactive oxygen species (ROS) generation from Aß-Cu. Overall, FeL1 is shown to bind to the Aß peptide, and modulate peptide aggregation. In addition, FeL1 forms a ternary species with Aß-Cu(ii) and impedes ROS generation, thus showing the promise of discrete metal complexes to limit the toxicity pathways of the Aß peptide.

Bifunctional ligand design for modulating mutant p53 aggregation in cancer.

Protein misfolding and aggregation contributes to the development of a wide range of diseases. In cancer, over 50% of diagnoses are attributed to p53 malfunction due to missense mutations, many of which result in protein misfolding and accelerated aggregation. p53 mutations also frequently result in alteration or loss of zinc at the DNA-binding site, which increases aggregation via nucleation with zinc-bound p53. Herein, we designed two novel bifunctional ligands, LI and LH , to modulate mutant p53 aggregation and restore zinc binding using a metallochaperone approach. Interestingly, only the incorporation of iodine function in LI resulted in modulation of mutant p53 aggregation, both in recombinant and cellular environments. Native mass spectrometry shows a protein-ligand interaction for LI , as opposed to LH , which is hypothesized to lead to the distinct difference in the p53 aggregation profile for the two ligands. Incorporation of a di-2-picolylamine binding unit into the ligand design provided efficient intracellular zinc uptake, resulting in metallochaperone capability for both LI and LH . The ability of LI to reduce mutant p53 aggregation results in increased restoration of p53 transcriptional function and mediates both caspase-dependent and -independent cell death pathways. We further demonstrate that LI exhibits minimal toxicity in non-cancerous organoids, and that it is well tolerated in mice. These results demonstrate that iodination of our ligand framework restores p53 function by interacting with and inhibiting mutant p53 aggregation and highlights LI as a suitable candidate for comprehensive in vivo anticancer preclinical evaluations.

Modification of Aß Peptide Aggregation via Covalent Binding of a Series of Ru(III) Complexes.

Alzheimer's disease (AD) is the most common form of dementia, leading to loss of cognition, and eventually death. The disease is characterized by the formation of extracellular aggregates of the amyloid-beta (Aß) peptide and neurofibrillary tangles of tau protein inside cells, and oxidative stress. In this study, we investigate a series of Ru(III) complexes (Ru-N) derived from NAMI-A in which the imidazole ligand has been substituted for pyridine derivatives, as potential therapeutics for AD. The ability of the Ru-N series to bind to Aß was evaluated by NMR and ESI-MS, and their influence on the Aß peptide aggregation process was investigated via electrophoresis gel/western blot, TEM, turbidity, and Bradford assays. The complexes were shown to bind covalently to the Aß peptide, likely via a His residue. Upon binding, the complexes promote the formation of soluble high molecular weight aggregates, in comparison to peptide precipitation for peptide alone. In addition, TEM analysis supports both amorphous and fibrillar aggregate morphology for Ru-N treatments, while only large amorphous aggregates are observed for peptide alone. Overall, our results show that the Ru-N complexes modulate Aß peptide aggregation, however, the change in the size of the pyridine ligand does not substantially alter the Aß aggregation process.

Electronic Structure and Reactivity Studies of a Nonsymmetric One-Electron Oxidized CuII Bis-phenoxide Complex.

The tetradentate mixed imino/amino phenoxide ligand (N-(3,5-di-tert-butylsalicylidene)-N'-(2-hydroxyl-3,5-di-tert-butylbenzyl))-trans-1,2-cyclohexanediamine (salalen) was complexed with CuII, and the resulting Cu complex (2) was characterized by a number of experimental techniques and theoretical calculations. Two quasi-reversible redox processes for 2, as observed by cyclic voltammetry, demonstrated the potential stability of oxidized forms, and also the increased electron-donating ability of the salalen ligand in comparison to the salen analogue. The electronic structure of the one-electron oxidized [2]+ was then studied in detail, and Cu K-edge X-ray Absorption Spectroscopy (XAS) measurements confirmed a CuII-phenoxyl radical complex in solution. Subsequent resonance Raman (rR) and variable temperature 1H NMR studies, coupled with theoretical calculations, showed that [2• ]+ is a triplet (S = 1) CuII-phenoxyl radical species, with localization of the radical on the more electron-rich aminophenoxide. Attempted isolation of X-ray quality crystals of [2• ]+ afforded [2H]+, with a protonated phenol bonded to CuII, and an additional H-bonding interaction with the SbF6 - counterion. Stoichiometric reaction of dilute solutions of [2• ]+ with benzyl alcohol showed that the complex reacted in a similar manner as the oxidized CuII-salen analogue, and does not exhibit a substrate-binding pre-equilibrium as observed for the oxidized bisaminophenoxide CuII-salan derivative.

Multifunctional Compounds for Activation of the p53-Y220C Mutant in Cancer.

The p53 protein plays a major role in cancer prevention, and over 50 % of cancer diagnoses can be attributed to p53 malfunction. The common p53 mutation Y220C causes local protein unfolding, aggregation, and can result in a loss of Zn in the DNA-binding domain. Structural analysis has shown that this mutant creates a surface site that can be stabilized using small molecules, and herein a multifunctional approach to restore function to p53-Y220C is reported. A series of compounds has been designed that contain iodinated phenols aimed for interaction and stabilization of the p53-Y220C surface cavity, and Zn-binding fragments for metallochaperone activity. Their Zn-binding affinity was characterized using spectroscopic methods and demonstrate the ability of compounds L4 and L5 to increase intracellular levels of Zn2+ in a p53-Y220C-mutant cell line. The in vitro cytotoxicity of our compounds was initially screened by the National Cancer Institute (NCI-60), followed by testing in three stomach cancer cell lines with varying p53 status', including AGS (WTp53), MKN1 (V143A), and NUGC3 (Y220C). Our most promising ligand, L5, is nearly 3-fold more cytotoxic than cisplatin in a large number of cell lines. The impressive cytotoxicity of L5 is further maintained in a NUGC3 3D spheroid model. L5 also induces Y220C-specific apoptosis in a cleaved caspase-3 assay, reduces levels of unfolded mutant p53, and recovers p53 transcriptional function in the NUGC3 cell line. These results show that these multifunctional scaffolds have the potential to restore wild-type function in mutant p53-Y220C.